FDA Approved: ALENDRONATE — Original Application (Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approved Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.'s generic alendronate (alendronate sodium tablets) via an Original Application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Osteoporosis
• Paget Disease of Bone

Drugs mentioned

• Alendronate Sodium Tablet (Alendronate sodium)

Snippet

ORIG AP for ALENDRONATE (ALENDRONATE SODIUM)